The immune
system produces antibodies in response to pathogen invasion. Antigens are the
collective term for the invasive bacteria, viruses, or other foreign molecules.
Antibodies are proteins, or polypeptides which have specific antigen
recognition sites. It is possible to have antibodies made using custom antibody
production when an antibody is required against a particular antigen but it is
not offered by a supplier. These antibodies can be either polyclonal or
monoclonal, depending on how they are produced and harvested. Polyclonal antibodies are capable of recognizing
multiple sites on an antigen. They are derived from different B-cell lineages.
Monoclonal antibodies recognize only one epitope or site on an antigen, and are
derived from a single B-cell line.
Global custom antibody service
market is estimated to be valued at US$
444.85 Million in 2022 and expected to reach US$ 930.46 million by 2030, witnessing
a CAGR of 9.7 % over
the forecast period (2022-2030).
Advantages
of using antibodies for various applications is projected to propel the market
growth over the forecast period.
Advantages of antibodies is
expected to increase their use for various applications such as research and
development, production of therapeutics, etc.
According to the National Center
for Biotechnology Information (NCBI): 2020, monoclonal antibodies and
polyclonal antibodies are widely used in gold standard techniques such as
ELISA, western blotting, flow cytometry, and other affinity based assays or
isolation techniques. For ELISA, a monoclonal antibody helps detect a specific
antigen of interest. Monoclonal antibodies can also help detect specific cells
in flow cytometry. They are also useful for protein purification. Monoclonal
antibody can further be used to bind a protein which can then be isolated from
its solution.
Global Custom Antibody Service Market – Impact
of Coronavirus (COVID-19) Pandemic
Since the COVID-19 outbreak in
December 2019, the disease has spread to over 100 countries across the globe.
The coronavirus (COVID 19) pandemic and consequent lockdown in various
countries across the globe have impacted the financial status of businesses in
all sectors. Supply chain and manufacturing activities have been disrupted
globally, due to lockdowns implemented by governments of countries, restricted
movement, and other COVID-19 safety precautions.
Comments
Post a Comment